ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

Jessica J. Holster; Marouan El Hassnaoui; Stijn Franssen; Jan N. M. IJzermans; Jeroen de Jonge; Bianca Mostert; Wojciech G. Polak; Roeland F. de Wilde; Marjolein Y. Homs; Bas Groot Koerkamp

doi:10.1245/s10434-022-11536-x

ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

Jessica J. Holster
, Marouan El Hassnaoui
, Stijn Franssen
, Jan N. M. IJzermans
, Jeroen de Jonge
, Bianca Mostert
, Wojciech G. Polak
, Roeland F. de Wilde
, Marjolein Y. Homs
, Bas Groot Koerkamp^*

^*Corresponding author for this work

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

Abstract

Hepatic arterial infusion pump (HAIP) chemotherapy
with floxuridine has been explored as a means to control cancer
in the liver. In this systematic review (https://doi.org/10.1245/
s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from nine
studies; survival outcomes of 154 patients were used in the
meta-analysis. HAIP chemotherapy with floxuridine for
patients with unresectable iCCA was associated with a pooled
3-year overall survival (OS) of 39.5% (95% confidence interval
(CI) 31.5–47.4%) and a weighted median OS of 29.0 months
(range 25.0–39 months).

Original language	English
Pages (from-to)	5541-5542
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	29
Issue number	9
Early online date	Mar 2022
DOIs	https://doi.org/10.1245/s10434-022-11536-x
Publication status	Published - Sept 2022

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1245/s10434-022-11536-x

Cite this

Holster, J. J., El Hassnaoui, M., Franssen, S., IJzermans, J. N. M., de Jonge, J., Mostert, B., Polak, W. G., de Wilde, R. F., Homs, M. Y., & Koerkamp, B. G. (2022). ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis. Annals of Surgical Oncology, 29(9), 5541-5542. https://doi.org/10.1245/s10434-022-11536-x

@article{0e018efa564d45209ab1cb98b4e0ed24,

title = "ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis",

abstract = "Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine has been explored as a means to control cancer in the liver. In this systematic review (https://doi.org/10.1245/ s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from nine studies; survival outcomes of 154 patients were used in the meta-analysis. HAIP chemotherapy with floxuridine for patients with unresectable iCCA was associated with a pooled 3-year overall survival (OS) of 39.5\% (95\% confidence interval (CI) 31.5–47.4\%) and a weighted median OS of 29.0 months (range 25.0–39 months).",

author = "Holster, \{Jessica J.\} and \{El Hassnaoui\}, Marouan and Stijn Franssen and IJzermans, \{Jan N. M.\} and \{de Jonge\}, Jeroen and Bianca Mostert and Polak, \{Wojciech G.\} and \{de Wilde\}, \{Roeland F.\} and Homs, \{Marjolein Y.\} and Koerkamp, \{Bas Groot\}",

note = "{\textcopyright} Society of Surgical Oncology 2022",

year = "2022",

month = sep,

doi = "10.1245/s10434-022-11536-x",

language = "English",

volume = "29",

pages = "5541--5542",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science+Business Media",

number = "9",

}

Holster, JJ, El Hassnaoui, M, Franssen, S , IJzermans, JNM , de Jonge, J , Mostert, B , Polak, WG , de Wilde, RF , Homs, MY & Koerkamp, BG 2022, 'ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis', Annals of Surgical Oncology, vol. 29, no. 9, pp. 5541-5542. https://doi.org/10.1245/s10434-022-11536-x

ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis. / Holster, Jessica J.; El Hassnaoui, Marouan; Franssen, Stijn et al.
In: Annals of Surgical Oncology, Vol. 29, No. 9, 09.2022, p. 5541-5542.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

AU - Holster, Jessica J.

AU - El Hassnaoui, Marouan

AU - Franssen, Stijn

AU - IJzermans, Jan N. M.

AU - de Jonge, Jeroen

AU - Mostert, Bianca

AU - Polak, Wojciech G.

AU - de Wilde, Roeland F.

AU - Homs, Marjolein Y.

AU - Koerkamp, Bas Groot

PY - 2022/9

Y1 - 2022/9

N2 - Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine has been explored as a means to control cancer in the liver. In this systematic review (https://doi.org/10.1245/ s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from nine studies; survival outcomes of 154 patients were used in the meta-analysis. HAIP chemotherapy with floxuridine for patients with unresectable iCCA was associated with a pooled 3-year overall survival (OS) of 39.5% (95% confidence interval (CI) 31.5–47.4%) and a weighted median OS of 29.0 months (range 25.0–39 months).

AB - Hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine has been explored as a means to control cancer in the liver. In this systematic review (https://doi.org/10.1245/ s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from nine studies; survival outcomes of 154 patients were used in the meta-analysis. HAIP chemotherapy with floxuridine for patients with unresectable iCCA was associated with a pooled 3-year overall survival (OS) of 39.5% (95% confidence interval (CI) 31.5–47.4%) and a weighted median OS of 29.0 months (range 25.0–39 months).

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000768614500005&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1245/s10434-022-11536-x

DO - 10.1245/s10434-022-11536-x

M3 - Meeting Abstract

C2 - 35288815

SN - 1068-9265

VL - 29

SP - 5541

EP - 5542

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 9

ER -

ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this